Christopher W Szeto

4PUBLICATIONS
29CO-AUTHORS
Predictive and prognostic markersTumour immunologyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 11, 2023
Caveolin Gene Expression Predicts Clinical Outcomes for Early-Stage HER2-Negative Breast Cancer Treated with Paclitaxel-Based Chemotherapy in the GeparSepto Trial.

Terence M Williams, Andreas Schneeweiss, Christian Jackisch

|Apr 04, 2023
Inferred Immune-Cell Activity Is an Independent Predictor of HER2-Negative Breast Cancer Prognosis and Response to Paclitaxel-Based Therapy in the GeparSepto Trial.

Peter A Fasching, Christopher Szeto, Carsten Denkert

|Mar 27, 2023
CD47-blocking Antibody ZL-1201 Promotes Tumor-associated Macrophage Phagocytic Activity and Enhances the Efficacy of the Therapeutic Antibodies and Chemotherapy.

Anthony Cao, Jiaqing Yi, Xinyan Tang

|Jan 30, 2020
A deep learning image-based intrinsic molecular subtype classifier of breast tumors reveals tumor heterogeneity that may affect survival.

Mustafa I Jaber, Bing Song, Clive Taylor

Pageof 1

Frequent Collaborators

2 joint publications

Peter A Fasching

2 joint publications

Carsten Denkert

2 joint publications

Christian Schem

2 joint publications

Karsten Weber